A new study reports that an artificial-intelligence tool can screen for type 2 diabetes by analyzing changes in a person’s speech, potentially delivering results within seconds. The approach focuses on speech patterns that may reflect metabolic differences associated with the condition.
The outlets describe the concept as a rapid, speech-based test that could be used for screening, rather than as a replacement for established diagnostic methods. Both sources frame the findings as early and based on a study demonstrating feasibility, without detailing how large the study was, what exact speech features were assessed, or what comparison tests were used. They also do not specify whether the method has been validated across diverse populations, environments, or languages. Overall, the reporting emphasizes speed and convenience—using voice input rather than blood tests—while leaving open questions about accuracy and real-world deployment.
